Dr. Hensley on Lynch Syndrome in Endometrial Cancer

Martee L. Hensley, MD
Published: Thursday, Dec 28, 2017



Martee L. Hensley, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses Lynch syndrome for patients with endometrial cancer.

According to Hensley, mismatch repair deficiency testing and microsatellite instability testing could better classify endometrial cancer, which can have treatment implications. This could increase the number of patients identified who might be carriers of germline mutations in mismatch repair enzymes.

If a patient has Lynch syndrome, that could affect the management decisions of the patient and their blood relatives, explains Hensley.
 


Martee L. Hensley, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses Lynch syndrome for patients with endometrial cancer.

According to Hensley, mismatch repair deficiency testing and microsatellite instability testing could better classify endometrial cancer, which can have treatment implications. This could increase the number of patients identified who might be carriers of germline mutations in mismatch repair enzymes.

If a patient has Lynch syndrome, that could affect the management decisions of the patient and their blood relatives, explains Hensley.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Publication Bottom Border
Border Publication
x